Pharmaceutical

STAT+: What we owe ALS patients — and why one company f...

What do you say to a patient when the FDA rejects “their” experimental drug — on...

STAT+: Obama-era Medicare innovation initiative doesn’t...

A key Obama-era initiative was supposed to save Medicare money by testing new po...

STAT+: More hospital and outpatient visits expected to ...

How much care is everyone actually getting, now that Covid-19 isn’t scaring so m...

Bracing for rough respiratory virus season, European of...

Officials in the U.K. and Europe are ramping up their campaigns urging eligible ...

Can the world still invent an HIV vaccine? Progress in ...

Even as the vaccine field has floundered, other sectors of HIV research have flo...

STAT+: Nobel Prize, in a rarity, celebrates a fruitful ...

In a rare moment for science’s top honor, this year's Nobel in medicine or physi...

STAT+: Congress extends some pandemic preparedness prog...

Congress temporarily extended a few pandemic-preparedness programs when it fores...

WHO recommends second malaria vaccine, hoping to addres...

Just two years after the WHO’s historic recommendation of the first malaria vacc...

STAT+: Verily lands $38 million deal with CDC for waste...

Alphabet’s life sciences company Verily has scored its first CDC contract, a hig...

The stability of $0 premiums in Medicare Advantage

Medicare Advantage plans really didn’t ratchet up their premiums for 2024, despi...

STAT+: Court strikes down Trump-era rule that allowed h...

A U.S. judge has struck down a Trump administration rule that allowed health ins...

STAT+: Former FDA official lays out how to keep patient...

Former FDA official Madris Kinard built a database to help patients, doctors, an...

Here’s what’s moving the needle in biotech stocks, in t...

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: Court allows Medicare drug price n...

A federal judge allowed the new Medicare drug price negotiation program to proce...

CDC proposes new antibiotics policy aimed at reducing STIs

The Centers for Disease Control and Prevention is proposing a new policy aimed a...

STAT+: Syndax’s leukemia drug succeeds in pivotal study

Syndax Pharmaceuticals’ treatment for a genetically defined form of advanced leu...